David Ege

David Ege

Chief Tech/Sci/R&D Officer at ADC THERAPEUTICS SA
52 year
Health Technology
Consumer Services
Commercial Services

Profile

David S.
Ege
is currently Chief Technical Officer at ADC Therapeutics SA since 2024.
Formerly, Dr. Ege was Chief Technology Officer & Executive VP at Seres Therapeutics, Inc. from 2020 to 2024, Executive Director-Vaccines & Biologics at Merck & Co., Inc. from 2015 to 2019, and President at Penn Biotech Group Healthcare Consulting.
Education includes a doctorate from the University of Pennsylvania and an undergraduate degree from Princeton University.

David Ege active positions

CompaniesPositionStart
ADC THERAPEUTICS SA Chief Tech/Sci/R&D Officer 01/10/2024

Former positions of David Ege

CompaniesPositionEnd
SERES THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 31/10/2024
MERCK & CO., INC. Corporate Officer/Principal 01/06/2019
President -
See the detail of David Ege's experience

Education of David Ege

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

94

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services